TMCnet News
Pershing Square Proposes 6 Directors For Allergan Board(dpa-AFX International Compact Via Acquire Media NewsEdge) WASHINGTON (dpa-AFX) - Pershing Square Capital Management, L.P. on Monday unveiled a slate of six highly experienced, independent directors for the board of directors of Botox maker Allergan, Inc. (AGN). The six members of the slate are: Betsy Atkins, Cathleen P. Black, Fredric N. Eshelman, Steven J. Shulman, David A. Wilson and John J. Zillmer. Commenting on the decision, Pershing Square CEO Bill Ackman said, "Each member of our slate of nominees is an independent, skilled leader with relevant domain, industry and/or executive management experience. By supporting this slate, Allergan shareholders can ensure that the interests of shareholders will be well represented on the board of Allergan." Pershing Square has previously announced that it is seeking to call a special meeting of Allergan shareholders. At the special meeting, Allergan shareholders will be able to voice their support for a number of critical matters, including the removal of six incumbent members of the Allergan board, the appointment of the independent Pershing Square slate and certain other actions to improve the corporate governance of Allergan. Copyright RTT News/dpa-AFX |